drugset

drugset / Trial / NCT01533532

A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)

NCT01533532 ↗

Phase 2 Completed 100 enrolled Kissei Pharmaceutical Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of KLH-2109 in patients with endometriosis.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	KLH-2109	Unknown	—	—

Indications